giemsa-diff-quick Search Results


90
Baxter Dade Diagnostic diff-quik differential white cell stain
Diff Quik Differential White Cell Stain, supplied by Baxter Dade Diagnostic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/diff+quick+modified+wright+giemsa+stain/pm07957829-83-10-7
Average 90 stars, based on 1 article reviews
diff-quik differential white cell stain - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Baxter Healthcare giemsa stain diff-quik
Giemsa Stain Diff Quik, supplied by Baxter Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/giemsa+solution+diff+quick/pm20189559-68-14-17
Average 90 stars, based on 1 article reviews
giemsa stain diff-quik - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dade Behring giemsa stain diff-quick
Giemsa Stain Diff Quick, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/modified+giemsa+stain+diff+quick/pm22936703-51-9-12
Average 90 stars, based on 1 article reviews
giemsa stain diff-quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nanjing Jiancheng Bioengineering Research Institute Co Ltd giemsa staining kit diff-quick
Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) <t>Giemsa</t> <t>staining</t> was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.
Giemsa Staining Kit Diff Quick, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/giemsa+staining+kit+diff+quick/pmc09097767-51-6-10
Average 90 stars, based on 1 article reviews
giemsa staining kit diff-quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Fisher Scientific modified wright-giemsa diff-quick
Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) <t>Giemsa</t> <t>staining</t> was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.
Modified Wright Giemsa Diff Quick, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/modified+wright+giemsa+diff+quick/pmc06368735-102-7-9
Average 90 stars, based on 1 article reviews
modified wright-giemsa diff-quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Baxter Dade Diagnostic giemsa-diff-quick
Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) <t>Giemsa</t> <t>staining</t> was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.
Giemsa Diff Quick, supplied by Baxter Dade Diagnostic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/giemsa+diff+quick/pmc04232063-140-11-12
Average 90 stars, based on 1 article reviews
giemsa-diff-quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Gamidor Technical Services Ltd may-grunwald giemsa stain diff-quick
Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) <t>Giemsa</t> <t>staining</t> was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.
May Grunwald Giemsa Stain Diff Quick, supplied by Gamidor Technical Services Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/may+grunwald+giemsa+stain+diff+quick/pm12847277-60-8-12
Average 90 stars, based on 1 article reviews
may-grunwald giemsa stain diff-quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Imeb Inc wright-giemsa based stain diff-stain
Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) <t>Giemsa</t> <t>staining</t> was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.
Wright Giemsa Based Stain Diff Stain, supplied by Imeb Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/rapid+modified+wright+giemsa+stain+diff+quick/pmc04109942-40-4-8
Average 90 stars, based on 1 article reviews
wright-giemsa based stain diff-stain - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dade Behring giemsa diff-quick, dade behring, newark, eua
Chrusciak‐Talhari 2011
Giemsa Diff Quick, Dade Behring, Newark, Eua, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/giemsa+diff+quick++dade+behring++newark++eua/pmc08094931-6086-163-160
Average 90 stars, based on 1 article reviews
giemsa diff-quick, dade behring, newark, eua - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Medion Diagnostics may-grünwald-giemsa staining diff quick
Chrusciak‐Talhari 2011
May Grünwald Giemsa Staining Diff Quick, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/may+gr%C3%BCnwald+giemsa+staining+diff+quick/pmc09421433-145-23-27
Average 90 stars, based on 1 article reviews
may-grünwald-giemsa staining diff quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bacto Laboratories giemsa stain diff quick
Chrusciak‐Talhari 2011
Giemsa Stain Diff Quick, supplied by Bacto Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/giemsa+stain+diff+quick/pmc01513581-50-0-14
Average 90 stars, based on 1 article reviews
giemsa stain diff quick - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dade Behring jenner–giemsa and romanovsky (diff-quick)
Chrusciak‐Talhari 2011
Jenner–Giemsa And Romanovsky (Diff Quick), supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/giemsa-diff-quick/jenner+giemsa+and+romanovsky++diff+quick+/pmc07159485-55-4-8
Average 90 stars, based on 1 article reviews
jenner–giemsa and romanovsky (diff-quick) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) Giemsa staining was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.

Journal: International Journal of Oncology

Article Title: Crosstalk between cancer and different cancer stroma subtypes promotes the infiltration of tumor-associated macrophages into the tumor microenvironment of oral squamous cell carcinoma

doi: 10.3892/ijo.2022.5368

Figure Lengend Snippet: Effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . (A) Giemsa staining was used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the activation and fusion of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate activated macrophages and red arrows indicate multinucleated giant cells. (B) Immunofluorescence staining were used to examine F4/80 and CD163 expression to identify the characteristics of activated macrophages and multinucleated giant cells. White arrows indicate activated macrophages and red arrow indicate multinucleated giant cells. Quantification of (C and D) the percentage of activated macrophages and (E and F) the percentage of multinucleated giant cells in the different groups. Data are presented as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.

Article Snippet: Giemsa staining was conducted using a Giemsa staining kit (Diff-Quick, Nanjing Jiancheng Bioengineering Institute).

Techniques: Activation Assay, In Vitro, Staining, Immunofluorescence, Expressing

Effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages following crosstalk with HSC-3 cells in vitro . (A) Transwell (migration) and Giemsa staining were used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages. Black arrows indicate spindle-shaped macrophages and red arrows indicate round-shaped macrophages. (B) Transwell (migration) and Giemsa staining were used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate spindle-shaped macrophages and red arrows indicate round-shaped macrophages. (C and D) Quantification of cell migration number in the different groups. Data are shown as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.

Journal: International Journal of Oncology

Article Title: Crosstalk between cancer and different cancer stroma subtypes promotes the infiltration of tumor-associated macrophages into the tumor microenvironment of oral squamous cell carcinoma

doi: 10.3892/ijo.2022.5368

Figure Lengend Snippet: Effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages following crosstalk with HSC-3 cells in vitro . (A) Transwell (migration) and Giemsa staining were used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages. Black arrows indicate spindle-shaped macrophages and red arrows indicate round-shaped macrophages. (B) Transwell (migration) and Giemsa staining were used to examine the effects of VSCC-SCs, SCC-SCs and HDFs on the migration of macrophages following crosstalk with HSC-3 cells in vitro . Black arrows indicate spindle-shaped macrophages and red arrows indicate round-shaped macrophages. (C and D) Quantification of cell migration number in the different groups. Data are shown as the mean ± SD of one independent experiment and the independent experiments were repeated in triplicate. Statistical analysis was performed using one-way ANOVA followed by Tukey's post hoc test. * P<0.05 and **** P<0.0001. ns, not significant (P>0.05); VSCC-SCs, verrucous squamous cell carcinoma-associated stromal cells; SCC-SCs, squamous cell carcinoma-associated stromal cells; HDFs, human dermal fibroblasts.

Article Snippet: Giemsa staining was conducted using a Giemsa staining kit (Diff-Quick, Nanjing Jiancheng Bioengineering Institute).

Techniques: Migration, In Vitro, Staining

Chrusciak‐Talhari 2011

Journal: The Cochrane Database of Systematic Reviews

Article Title: Interventions for American cutaneous and mucocutaneous leishmaniasis

doi: 10.1002/14651858.CD004834.pub3

Figure Lengend Snippet: Chrusciak‐Talhari 2011

Article Snippet: Reasons not provided Selective reporting (reporting bias) Unclear risk No information provided Other bias High risk Sample size calculation was not adequately reported Open in a separate window Chico 1995 Study characteristics Methods Study design: Single‐centre phase II/III randomised clinical trial Setting/location: dermatology outpatient clinic at the Fundação de Medicina Tropical—Amazonas, Manaus, AM, Brazil Period of study: February 2007 to December 2008 Sample size calculation: “The sample size was calculated assuming an expected 30% difference between groups (effectiveness of at least 50% for meglumine and 80% for miltefosine), 95% confidence interval (CI) and a power of 80%.” Participants Type of Leishmania: 86 L. ( V. ) guyanensis; 3 L. ( V. ) braziliensis; 1 L. ( V. ) lainsoni Inclusion criteria: 1) clinical diagnosis of CL with 1 – 5 lesions with at least 1 ulcerated lesion with a diameter of 1 – 5 cm; 2) illness duration of < 3 months; 3) visualisation of Leishmania amastigotes on Giemsa Diff‐Quick, Dade Behring, Newark, EUA stained imprint from lesion biopsies; 4) no previous leishmania treatment Exclusion criteria: 1) evidence of immunodeficiency or antibodies to HIV; 2) pregnancy or patients not willing or unable to use contraceptives during and 3 months after the end of therapy; 3) ALT, AST ≥ 3× normal reference values, Billirubin ≥ 2× reference values, and creatinine and blood urea nitrogen (BUN) ≥ 1.5× normal reference values; 4) any evidence of serious underlying disease (cardiac, renal, hepatic, or pulmonary) including serious infection other than CL Randomised: 90 (60 Miltefosine, 30 Glucantime) Withdrawals: “ Only three patients were lost in follow‐up: two in the miltefosine group (second‐ and fourth‐month visits) and one in the antimonial group (fourth‐month visit)”.

Techniques: Biomarker Discovery, Staining, AST Assay, Infection, Capsules, Control, Injection, Sequencing, Selection